HIV AIDS

>

Latest News

 Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision / image credit ©Waldenmarus/stock.adobe.com
Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision

June 19th 2025

The only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.

Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV / Image credit: ©Sherry Young/AdobeStock
Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV

March 19th 2025

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Real-World Use of Cabotegravir for HIV PrEP

October 25th 2023

IDWeek 2023: New Data Provides Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP / Image credit: ©Chris Bjornberg/AdobeStock
IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP

October 15th 2023

Image credit HIV  ©Chris Bjornberg/Shutterstock.com
In People Living with HIV, Switch from Oral ART to Long-Acting Injectable Significantly Improved Adherence, Persistence

October 11th 2023

More News

© 2025 MJH Life Sciences

All rights reserved.